EUVIMED · CrossrefJournal
Journal of Global Antimicrobial Resistance
ISSN 2213-7165 · Elsevier BV
Latest articles
Clonal diversity and genetic characteristics of extraintestinal pathogenic Escherichia coli in northern Japan: Identification of the potentially prevalent clones phylogroup B2-ST357 and ST1193
Unexplained colistin resistance in Klebsiella pneumoniae: Insights into sRNA-mediated post-transcriptional regulation
Association of cirA allelic variation with cefiderocol susceptibility and virulence-associated lineages in Klebsiella pneumoniae
High prevalence of hypervirulent Staphylococcus aureus CC22-t309 in paediatric osteomyelitis and septic arthritis in China
Outpatient parenteral antimicrobial therapy (OPAT) guidelines: A systematic review
Exploring the evidence for use of cefiderocol as part of combination therapies: A systematic review of in vitro, in vivo, and clinical studies
Eleven-year surveillance of Pseudomonas aeruginosa infections and antimicrobial resistance trends in a Portuguese tertiary hospital, 2014 - 2024: Trends and insights into novel agents
Comparison of the in vitro activities of ceftazidime-avibactam and ceftolozane-tazobactam against clinical isolates of Pseudomonas aeruginosa: ATLAS global surveillance programme 2020–2024
Penicillin susceptibility in Staphylococcus aureus from blood isolates: A multicentre surveillance study in Denmark, Iceland, Norway and Sweden
Global Genomic Analysis of Antimicrobial Resistance in Streptococcus pyogenes
Clinical Outcomes of Carbapenem-Resistant versus Carbapenem-Susceptible Pseudomonas aeruginosa Infections in Japan: A Multicenter Matched Case-Control Study by the Multi-Drug Resistant Organisms Clinical Research Network (MDRnet)
Prior ceftriaxone susceptibility and current nonsusceptibility in paired urinary isolates over time: a retrospective longitudinal cohort study
In Vitro Activity of Cefiderocol against Carbapenem-Resistant Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii and the Cefiderocol Resistance Mechanisms
Molecular epidemiological characteristics and recent trend of methicillin-resistant Staphylococcus aureus (MRSA) in northern Japan: the shift of major clonal group to CC1-IV (ST1/ST2725, spa-t1784) and occurrence of various novel MRSA clones
Characterization of a lytic phage Vp16M (genus Maculvirus) and its endolysin against Vibrio parahaemolyticus
Genomic Characterization of a Novel KPC-243-Producing Carbapenem-Resistant Pseudomonas aeruginosa ST463 strain
Co-occurrence of mecA and cfr in Staphylococcus saprophyticus isolated from bulk tank milk
Occurrence and characterization of ESBL- and AmpC-producing Escherichia coli in the common tern (Sterna hirundo) and surface water of Bahía Samborombón, Argentina
PMA-qPCR for viability and phenotypic antibiotic susceptibility testing of Acinetobacter baumannii to four mechanistically distinct antibiotics in bronchoalveolar lavage
Pathogenesis and genomic architecture of azole-resistant Candida albicans isolated from the male genitourinary tract
Isolation of clonal Klebsiella pneumoniae strains with diverse blaNDM-5 and blaOXA-181 carriage status during cefiderocol treatment in an immunocompromised patient with multiple lung abscesses
Dalbavancin as sequential therapy for complex osteoarticular infections: a single-center case series
In vitro activity of imipenem/relebactam against Enterobacterales isolates from China: results from the Study of Monitoring Antimicrobial Resistance Trends (SMART), 2020-2022
Clinical impact of third-generation cephalosporin resistance in hospitalized patients with upper urinary tract infections: a retrospective propensity score-matched study
Exploring the impact of antimicrobial resistance on sustainable development goal 3 in low and middle income countries: A scoping review
Diagnostic labelling, antibiotic appropriateness and watch use for upper respiratory infections in Singapore primary care: A multicentre retrospective study
In vitro activity of cefiderocol against clinically relevant Gram-negative bacilli collected in China in 2023
Aztreonam-avibactam and cefiderocol against metallo-β-lactamase-producing Enterobacterales and other carbapenem-resistant Gram-negative pathogens: Microbiological activity and clinical evidence
Molecular characteristics and antimicrobial susceptibility profiling of carbapenem-resistant Pseudomonas aeruginosa clinical isolates in Korea: Implications for novel β-lactam therapy
Time-series analysis of antimicrobial use and resistance trends in a tertiary hospital in China from 2017 to 2022: Implications for national stewardship efforts
EUVIMED